Camille L Bedrosian Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Camille L Bedrosian.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Camille L Bedrosian. Camille L Bedrosian is VP, Chief Medical Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and EVP and Chief Medical Officer in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX).

Latest Insider Trading Transactions of Camille L Bedrosian

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ARIA, CRNX, RYTM, RARE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 10 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	113.67	364	41,376	38,775	39.1 K to 38.8 K (-0.93 %)
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	M	55.00	5,000	275,000	58,000
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	109.09	5,000	545,450	39,139	44.1 K to 39.1 K (-11.33 %)
Apr 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Buy	M	55.00	5,000	275,000	44,139	39.1 K to 44.1 K (+12.77 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	142.47	11,000	1,567,170	11,000
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	138.18	4,543	627,752	39,139	43.7 K to 39.1 K (-10.40 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	4,636	0	43,682	39 K to 43.7 K (+11.87 %)
Mar 03 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	5,500	0	39,046	33.5 K to 39 K (+16.40 %)
Feb 02 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	140.36	2,243	314,827	33,546	35.8 K to 33.5 K (-6.27 %)
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	M	55.00	25,000	1,375,000	63,000
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	139.18	25,000	3,479,500	35,789	60.8 K to 35.8 K (-41.13 %)
Jan 19 2021	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Buy	M	55.00	25,000	1,375,000	60,789	35.8 K to 60.8 K (+69.85 %)
Dec 11 2020	RYTM	RHYTHM PHARMACEUTI ...	Bedrosian Camille L	Director	Option Exercise	A	28.27	37,000	1,045,990	37,000
Oct 16 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Sell	S	88.00	262	23,056	35,789	36.1 K to 35.8 K (-0.73 %)
Sep 03 2020	CRNX	Crinetics Pharmace ...	Bedrosian Camille L	Director	Option Exercise	A	16.08	25,000	402,000	25,000
May 08 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	66.26	249	16,499	36,051	36.3 K to 36.1 K (-0.69 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	56.08	21,000	1,177,680	21,000
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	56.08	1,249	70,044	36,300	37.5 K to 36.3 K (-3.33 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	5,634	0	37,549	31.9 K to 37.5 K (+17.65 %)
Mar 03 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	7,300	0	31,915	24.6 K to 31.9 K (+29.66 %)
Jan 31 2020	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	53.23	1,624	86,446	24,615	26.2 K to 24.6 K (-6.19 %)
Oct 16 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	1,437	0	26,239	24.8 K to 26.2 K (+5.79 %)
May 07 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	1,438	0	24,802	23.4 K to 24.8 K (+6.15 %)
Feb 15 2019	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Payment of Exercise	F	48.85	1,636	79,919	16,364	18 K to 16.4 K (-9.09 %)
Jan 31 2018	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Option Exercise	A	55.00	88,000	4,840,000	88,000
Jan 31 2018	RARE	Ultragenyx Pharmac ...	Bedrosian Camille L	EVP and Chief Medic ...	Grant	A	0.00	18,000	0	18,000	0 to 18 K
Apr 18 2007	ARIA	ARIAD PHARMACEUTIC ...	Bedrosian Camille L	VP, Chief Medical O ...	Option Exercise	A	4.49	30,000	134,700	30,000
Oct 06 2005	ARIA	ARIAD PHARMACEUTIC ...	Bedrosian Camille L	VP, Chief Medical O ...	Option Exercise	A	7.56	70,000	529,200	70,000

Page: 1